Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Psychiatrie
»
Schizophrenie und Psychosen
21. April 2026
Suchen
medline.ch
Schizophrenie und Psychosen
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Angst- und Panikstörungen
Demenz
Depression
Essstörungen
Persönlichkeits- störungen
Schizophrenie und Psychosen
Schlafstörungen
Sexuelle Störungen
Somatoforme Störungen
Sucht
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 3430
Artikel 1 - 20 / 68590
Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study.
Front Psychiatry
Shen Y, Wang D, Li Z.
PMID: 42006049 [PubMed]
Validation of the cognitive fusion questionnaire in regular meditators and persons with schizophrenia spectrum disorders.
Front Psychol
Bergmann N, Conell I, Hahne I, Zierhut M, Ta TMT, Hahn E, Böge K.
PMID: 42005019 [PubMed]
Jumping to conclusions and social behavior in individuals diagnosed with schizophrenia.
Schizophr Res Cogn
Hayashi R, Takahama Y, Inadomi H, Ishii R, Watanabe S, Yoshida K, Okada H, Yoshimura M.
PMID: 42004482 [PubMed - as supplied by publisher]
Developmental trajectories of social responsiveness and theory of mind in adolescent offspring at familial high-risk of schizophrenia or bipolar disorder and population-based controls-The Danish High Risk and Resilience Study, VIA 15.
Br J Clin Psychol
Veddum L, Laursen AF, Bundgaard AF, Hemager N, Gregersen M, Krantz MF, Vaskinn A, Jepsen JRM, Søndergaard A, Rohd SB, Wilms M, Schiavon M, Streymá DHB, Thorup AAE, Nordentoft M, Mors O, Greve AN.
PMID: 42003073 [PubMed - as supplied by publisher]
Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure.
Pak J Pharm Sci
Wu Y, Wu J, Deng Z, Xiao T.
PMID: 42001294 [PubMed - indexed for MEDLINE]
Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling.
Transl Psychiatry
Arjmand S, Chaudhary M, Samudyata, Piehl F, Pelanis A, Engberg G, Cervenka S, Landén M, Erhardt S, Sellgren CM.
PMID: 42000733 [PubMed - indexed for MEDLINE]
Task-based fNIRS biomarkers of HD-tDCS treatment for negative symptoms in schizophrenia.
Schizophr Res
Lin CE, Chen LF, Sack AT, Chang HA.
PMID: 42000633 [PubMed - as supplied by publisher]
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.
Biol Psychiatry Cogn Neurosci Neuroimaging
Bello D, Connolly JG, Addington J, Bearden CE, Cadenhead K, Cannon TD, Cornblatt B, Keshavan M, Mathalon DH, Perkins DO, Seidman L, Stone WS, Tsuang MT, Walker EF, Woods S, Brady RO Jr, Carrión RE, Ward HB.
PMID: 41999882 [PubMed - as supplied by publisher]
What are the experiences of people with psychosis, their carers and staff in inpatient mental healthcare services in the United Kingdom? A systematic review and meta-ethnography.
Br J Clin Psychol
MacDonald-Winship LA, Schröder TA, Lane S.
PMID: 41999092 [PubMed - as supplied by publisher]
Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS).
Trials
Johansen JF, Nielsen MØ, Kragh M, Nielsen J.
PMID: 41998739 [PubMed - indexed for MEDLINE]
Finding risk factors for dementia in patients with schizophrenia: a population-based case-control study.
BMC Psychiatry
Ho CP, Hsu KL, Chang WC, Hsieh TC.
PMID: 41998529 [PubMed - as supplied by publisher]
Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions.
Neuroscience
Casile A, Sapienza J, Vasciaveo V, Barzon B, Nasini S, Guarato G, Ave C, Martini F, Bosia M, Comai S.
PMID: 41997556 [PubMed - as supplied by publisher]
Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosis.
Schizophr Res
Gago E, Montalvo I, Cabezas Á, Ortega L, Solé M, Martorell L, Vilella E, García-Rizo C, Labad J.
PMID: 41996952 [PubMed - as supplied by publisher]
Common molecular signatures: the role of BDNF, melatonin, and orexin in the ASD-schizophrenia continuum.
Mol Biol Rep
Alruwaili NS, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Bogari NM, Alhelfawi S, Alruwaili M, El-Saber Batiha G.
PMID: 41995757 [PubMed - in process]
Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis.
Front Psychiatry
Kristensen TD, Ebdrup BH, Ambrosen KS, Nordentoft M, Glenthøj LB, Grasshof S.
PMID: 41993838 [PubMed]
Dose effect of buspirone combined with clozapine on cognitive function in patients with schizophrenia.
Br J Clin Pharmacol
Xia Y, Song C, Zhang J, Zhu W, Xu H.
PMID: 41992539 [PubMed - as supplied by publisher]
Long-term regular follow-up yields important benefits in forensic psychiatric patients with psychosis: A 2-year longitudinal study on psychopathology, general health, quality of life, and functioning.
J Forensic Sci
Bali P, Markopoulou M, Douzenis P, Tasios K, Rizos E, Michopoulos I, Douzenis A.
PMID: 41992431 [PubMed - as supplied by publisher]
Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
Am J Psychiatry
Ku SH, Stringfield SJ, Torregrossa MM, Sweet RA, Chou S.
PMID: 41992094 [PubMed - as supplied by publisher]
Neural underpinnings of verbal memory encoding and recognition impairments in individuals with clinically stable mood or schizophrenia spectrum disorders.
Psychiatry Res Neuroimaging
Segerlin SV, Damgaard V, Jespersen AE, Schandorff JM, Thommesen KK, Sankar A, Fisher PM, Macoveanu J, Miskowiak KW.
PMID: 41990724 [PubMed - as supplied by publisher]
Are routinely collected clinical and sociodemographic characteristics associated with social functioning and activities of daily living in schizophrenia? A machine learning approach descriptive of a schizophrenia cohort.
PLoS One
Barbalat G, Plasse J, Chéreau-Boudet I, Gouache B, Guillard-Bouhet N, Legros-Lafarge E, Franck N.
PMID: 41990013 [PubMed - indexed for MEDLINE]
Artikel 1 - 20 / 68590
Seite 1 von 3430
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung